Status:
COMPLETED
Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-control Study.
Lead Sponsor:
Cairo University
Conditions:
Oral Lichen Planus
Leptin Levels
Eligibility:
All Genders
30-70 years
Brief Summary
This study aims to evaluate the levels of leptin in both saliva and serum samples of patients diagnosed with oral lichen.
Detailed Description
Oral lichen planus is a frequently encountered chronic muco-cutaneous condition with a high prevalence rate. The condition can be classified as an autoimmune disorder.Although the exact cause of this ...
Eligibility Criteria
Inclusion
- Ages for both sexes fall between 30 and 70.
- Symptomatic OLP has been diagnosed clinically and verified histologically.
- Participants who sign a written consent form after being fully informed about the study.
Exclusion
- Treatment with a systemic or locally administered systemic medication within the previous three months before the commencement of the research.
- Patients now taking or who have just stopped taking an NSAIDs (both steroidal and non steroidal) for pain or inflammation.
- Patients who have been diagnosed with a malignant tumor or tumors.
- Women who are expecting or nursing.
- Inmates, the mentally ill, the elderly, etc, all fall into this category.
Key Trial Info
Start Date :
December 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06078579
Start Date
December 30 2023
End Date
December 30 2024
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo university
Cairo, Egypt